08.01.2013 - Dutch RNA therapies specialist Prosensa (Leiden) has hired the former Genzyme CEO Henri Termeer as Strategic Advisor.
His role at Prosensa will be to provide input on the company’s corporate strategy and growth plans.Termeer served as Chairman, President and CEO of Genzyme Corporation for nearly three decades. Under his leadership, the company evolved from a mid-sized biomedical company to one of the world’s leading biopharmaceutical companies, specialising in the field of orphan drugs. He retired from Genzyme in 2011 following its acquisition by Sanofi. Termeer is also involved in a number of other companies and not-for-profit.http://www.european-biotechnology-news.com/people/bio-people/2012-2/henri-termeer.html